Canopy Growth's cannabis business is showing signs of a turnaround, with revenue growth, improving m

Shares of Tilray Brands (NASDAQ:TLRY) are up 6% to $4.75 Wednesday afternoon, participating in a bro

Canadian cannabis stocks are once again gaining attention as investors search for opportunities with

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or t

Curaleaf's bid signals cannabis consolidation is accelerating. Canopy Growth could emerge as another

With November's pivotal midterm elections fast approaching, cannabis reform is emerging as an issue.

Renewed certification maintains Kincardine’s role in Canopy Growth’s EU GMP flower supply chainCanop

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or t

Curaleaf recently announced plans for a takeover of Aurora Cannabis, a rival of Canopy Growth. Canop

Canopy Growth NASDAQ: CGC is positioning itself for further expansion in medical cannabis, European

Canopy's balance sheet is finally improving. Medical cannabis is driving the strongest growth.

The United States is slowly moving toward the legalization of marijuana.  The next big step is the r

Canopy Growth NASDAQ: CGC reported first-quarter fiscal 2027 net revenue of C$81.2 million, up 13% f

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) reported continued revenue growth across its business

Canopy Growth Corporation (NASDAQ:CGC) on Friday reported a first-quarter fiscal 2027 loss of two ce

Canopy Growth beats first-quarter estimates as revenue rises 13%, medical cannabis sales increase, a

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.02 per share versus the Zacks C

Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Reports First Quarter Fiscal Year 2027 Financi

Canopy Growth (NASDAQ:CGC) reported quarterly losses of $(0.02) per share which beat the analyst con

The DEA's decision on rescheduling cannabis is the next key catalyst for Canopy Growth. A decision c

Canopy Growth Corporation (CGC) reached $0.89 at the closing of the latest trading day, reflecting a

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC) will

Canopy Growth (NASDAQ:CGC) reported quarterly losses of $(0.29) per share which missed the analyst c

https://www.benzinga.com/markets/equities/26/06/53113507/trump-says-iran-took-too-long-and-will-pay-

https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amend

https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec

Akanda Corp. (NASDAQ: AKAN) stock surges over 50% Wednesday. Learn how DOJ regulatory shifts and low

Akanda stock surges as U.S. moves to reclassify marijuana, lifting cannabis stocks and fueling stron

Canopy Growth Corp (NASDAQ:CGC) shares are falling Thursday, pulling back after Wednesday's rall

https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3

Akanda Corp. shares jump 33.69% after hours following a 214% intraday surge.

Cannabis ETFs surge as Trump signals Schedule III reclassification, boosting profit outlook and inve

Shares of Canopy Growth (NASDAQ: CGC) are surging Wednesday afternoon following news of a potential

Trump is reportedly set to reclassify marijuana this week, but Polymarket traders put the odds at ju

https://www.axios.com/2026/04/22/trump-marijuana-rule-change

https://www.marijuanamoment.net/white-house-schedules-meeting-on-cannabis-products-enforcement-polic

https://www.marijuanamoment.net/marijuana-businesses-could-list-on-us-stock-exchanges-like-nasdaq-an

https://cannabiswire.com/newsletters/scoop-medicare-cbd-pilot-will-allow-some-thc-in-products/?free_

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC)

https://www.marijuanamoment.net/federal-agency-finalized-rule-for-cbd-medicare-coverage-pilot-progra

https://www.marijuanamoment.net/gop-congressman-isnt-sure-marijuana-rescheduling-is-a-doj-priority-b

Canopy Growth (NASDAQ:CGC) reported quarterly losses of $(0.13) per share which missed the analyst c

Canopy Gwth (TSX:WEED) reported quarterly losses of $(0.18) per share. This is a 83.78 percent incre